Express Scripts Holding - M&A Summary, Ownership, and Business Overview

Healthcare ServicesCompany

Express Scripts Holding M&A Summary

Express Scripts Holding has acquired 17 companies of its own, including 1 in the last 5 years. A total of 5 acquisitions came from private equity firms. It has also divested 4 assets.

Express Scripts Holding’s largest acquisition to date was in 2009, when it acquired NextRx subsidiaries for $4.7B. Express Scripts Holding has acquired in 10 different US states. The Company’s most targeted sectors include healthcare services (60%) and business services (14%).

Express Scripts Holding Ownership

Who owns Express Scripts Holding?

Express Scripts Holding is owned by The Cigna Group. It was acquired on March 8, 2018.

Express Scripts Holding Business Overview

Where is Express Scripts Holding headquartered?

Express Scripts Holding is headquartered in St. Louis, Missouri.

What is Express Scripts Holding’s revenue?

Express Scripts Holding disclosed revenue of 100,065M USD for 2017 and 100,288M USD for 2016.

How many employees does Express Scripts Holding have?

Express Scripts Holding has 25,900 employees.

What sector is Express Scripts Holding in?

Express Scripts Holding is a healthcare services company.

When was Express Scripts Holding founded?

Express Scripts Holding was founded in 1986.

M&A Summary

  • M&A Total Activity19
    • M&A Buy Activity15
    • M&A Sell Activity4
  • Total Sectors Invested 6
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 13
  • M&A Advisors 5

Express Scripts Holding Co.

One Express Way,
St. Louis, Missouri 63121
United States,
(314) 996-0900
www.express-scripts.com

Express Scripts Holding Co. is a provider of integrated pharmacy-benefit management services. Services include network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. Express Scripts Holding Co. was formed in 1986 and is based in St. Louis, Missouri.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 15 - - - - - 15
vol $10.7B $10.7B
Sell (0.0/yr) # 4 - - - - - 4
  19

Most Recent M&A

Company Date Value Type
Verity Solutions Group, Inc. 2019-10-02 - Add-on Acquisition
Kirkland, Washington · www.verity340b.com
United BioSource Corp. 2017-11-27 - Divestiture
Blue Bell, Pennsylvania · www.ubc.com
EviCore Healthcare LLC 2017-10-10 3.6B USD Add-on Acquisition
Bluffton, South Carolina · www.evicore.com
myMatrixx 2017-05-17 - Add-on Acquisition
Tampa, Florida · www.mymatrixx.com
United BioSource Corp. 2013-12-09 - Divestiture
Blue Bell, Pennsylvania · www.ubc.com
Envision Pharma, Inc. 2013-06-18 - Divestiture
Horsham, United Kingdom · www.envisionpharmagroup.com
ConnectYourCare LLC 2012-08-31 - Divestiture
Hunt Valley, Maryland · www.connectyourcare.com
Medco Health Solutions, Inc. 2012-04-02 - Merger
Franklin Lakes, United States · www.medcohealth.com
NextRx subsidiaries 2009-12-01 4.7B USD Divestiture
, United States
Medical Service Co. 2008-07-22 - Add-on Acquisition
Bedford, Ohio · www.medicalserviceco.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Healthcare Services 9 (60%) 4.7B (44%) 2 (50%) -
Business Services 2 (13%) 4.7B (44%) - -
Life Science 1 (7%) - 1 (25%) -
Distribution 1 (7%) 1.3B (12%) - -
Internet Software and Services 1 (7%) - - -
Software 1 (7%) - - -
Information Technology - - 1 (25%) -
Total 15 $10.7B 4 -

By Geo

State/Country Buy Value Sell Value
United States 15 10.7B 3 -
  Florida 3 1.3B - -
  Pennsylvania 2 - 1 -
  Missouri 1 - 1 -
  Maryland 1 - 1 -
  Washington 1 - - -
  South Carolina 1 3.6B - -
  Ohio 1 - - -
  New Jersey 1 - - -
  Montana 1 700M - -
United Kingdom - - 1 -
Domestic 15 (100%) 10.7B (100%) 3 (75%) -
Cross-border - - 1 (25%) -
Total 15 $10.7B 4 -

Top M&A Advisors

Financial Deals
Lazard Ltd.
1
Triple Tree LLC
1
Centerview Partners
1
Legal Deals
Skadden, Arps, Slate, Meagher & Flom
2
Bryan Cave Leighton Paisner LLP
1

Deal Values

buy # Total
> $1B 3 $9.6B
$100M to $1B 2 $1.1B
TOTAL $10.7B
Largest NextRx subsidiaries
$4.7B (2009-12-01)

M&A Connections

Deals
Acquired from
Investor(s)
20%
3 (20%)
Strategic(s)
27%
4 (27%)
Divested to
Investor(s)
75%
3 (75%)
Strategic(s)
25%
1 (25%)

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.